Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine
ContributorsOpravil, Milos; Baumann, Doris; Chave, Jean-Philippe; Furrer, Hansjakob; Calmy, Alexandra
Published inAIDS, vol. 18, no. 16, p. 2213-2215
Publication date2004-11-05
Keywords
- Adult
- Antiretroviral Therapy, Highly Active
- Dideoxynucleosides / administration & dosage
- Female
- Follow-Up Studies
- HIV Infections / drug therapy
- HIV Protease Inhibitors / therapeutic use
- Humans
- Lamivudine / administration & dosage
- Male
- Middle Aged
- Prospective Studies
- Reverse Transcriptase Inhibitors / therapeutic use
- Time Factors
- Treatment Failure
- Zidovudine / administration & dosage
Affiliation entities
Research groups
Citation (ISO format)
OPRAVIL, Milos et al. Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine. In: AIDS, 2004, vol. 18, n° 16, p. 2213–2215. doi: 10.1097/00002030-200411050-00019
Main files (1)
Article (Published version)
Identifiers
- PID : unige:176244
- DOI : 10.1097/00002030-200411050-00019
- PMID : 15577660
Additional URL for this publicationhttps://journals.lww.com/aidsonline/fulltext/2004/11050/long_term_efficacy_after_switch_from_protease.19.aspx
Journal ISSN0269-9370
